semaglutide fibrosis in MASH with F2-F3 fibrosis: a holistic perspective on the ESSENCE phase 3 trial GI and Hepatology News -

Researchers analyzed data from 1,432 adults (mean age of 61, 48.6% female) with type 2 diabetes who experienced STEMI while taking tirzepatide or GLP-1RAs and continued using the same medication between 2022 and 2023

Seek medical attention if you experience Bloating that worsens progressively over 2+ weeks despite strict dietary compliance Severe abdominal pain that limits daily activities Inability to eat more than a few bites without feeling painfully full Vomiting undigested food 4+ hours after eating No bowel movement for 4+ days despite fiber and hydration Blood in stool or vomit Unexplained fever with abdominal distension Right upper quadrant pain (possible gallbladder involvement) Signs of dehydration (dark urine, dizziness, rapid heart rate) Your healthcare provider may order imaging studies, adjust your semaglutide dose, prescribe prokinetic medications to support gastric emptying, or evaluate for conditions unrelated to semaglutide that may be contributing to the symptoms

doi: 10.3389/fpsyt.2024.1364858 60 MirzaR.SharmaB

Can this combo help with tanning and sun damage

Mastrandrea Lucy, D